Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.316100744366269 | N/A |
Market Cap | $27.28M | N/A |
Shares Outstanding | 86.31M | 19.16% |
Employees | 0 | N/A |
Shareholder Equity | 81.31M | 41.92% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 1.25 | N/A |
P/B Ratio | 0.34 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0469 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $21.87M | N/A |
Earnings | -$3.81M | N/A |
Gross Margin | 0.6852 | N/A |
Operating Margin | -0.6355 | N/A |
Net income margin | -0.1744 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $68.87M | N/A |
Total Debt | $1.74M | N/A |
Cash on Hand | $16.76M | N/A |
Debt to Equity | 0.1672 | -59.65% |
Cash to Debt | $9.63 | 32.85% |
Current Ratio | $2.75 | -16.13% |